SeLux Diagnostics, Inc.
Charlestown, US · Founded 2014 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
ES
Eric SternExecutive Officer, Director, Promoter
JP
James Parker CassidyDirector
SY
Scott YapheDirector
SE
Steven E. LufkinExecutive Officer, Director
AV
Aleksandar VacicExecutive Officer, Promoter
MR
Michael RubinDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$40MraisedFeb 2024 · 9 investors · BiotechnologyRule 506(b)
▶$40MraisedFeb 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michele HealyExecutive Officer
- Jamie CondieDirector
- Orhan GazelleDirector
- John WilsonExecutive Officer
- Eric SternExecutive Officer, Director
- Ingo ChakravartyDirector
- Steven E. LufkinExecutive Officer, Director
- James Parker CassidyDirector
- Erich SchellerDirector
- Adam SteelExecutive Officer
- Aleksandar VacicExecutive Officer
- Offering amount
- $45M
- Amount sold
- $40M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$48.2MraisedFeb 2022 · 25 investors · BiotechnologyRule 506(b)
▶$48.2MraisedFeb 2022 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott YapheDirector
- Aleksandar VacicExecutive Officer
- James Parker CassidyDirector
- Eric SternExecutive Officer, Director
- Erich SchellerDirector
- Jack PercoskieExecutive Officer
- Steven E. LufkinExecutive Officer, Director
- Offering amount
- $57.6M
- Amount sold
- $48.2M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJun 2021 · 25 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJun 2021 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven E. LufkinExecutive Officer, Director
- Parker CassidyDirector
- Vacic AlexanderExecutive Officer
- Stephen ZacharyDirector
- Eric SternExecutive Officer, Director
- Jack PercoskieExecutive Officer
- Scott YapheDirector
- Offering amount
- $7.5M
- Amount sold
- $2.5M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$813.9KraisedOct 2020 · 1 investors · BiotechnologyRule 506(b)
▶$813.9KraisedOct 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven E. LufkinExecutive Officer, Director
- Aleksandar VacicExecutive Officer, Promoter
- Eric SternExecutive Officer, Director, Promoter
- James Parker CassidyDirector
- Stephen ZacharyDirector
- Jack PercoskieExecutive Officer
- Scott YapheDirector
- Offering amount
- $1.7M
- Amount sold
- $813.9K
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedSep 2019 · 27 investors · BiotechnologyRule 506(b)
▶$9MraisedSep 2019 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven E. LufkinExecutive Officer, Director
- Aleksandar VacicExecutive Officer, Promoter
- Eric SternExecutive Officer, Director, Promoter
- James Parker CassidyDirector
- Scott YapheDirector
- Stephen ZacharyDirector
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$23.5MraisedApr 2018 · 5 investors · BiotechnologyRule 506(b)
▶$23.5MraisedApr 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric SternExecutive Officer, Director, Promoter
- James Parker CassidyDirector
- Scott YapheDirector
- Steven E. LufkinExecutive Officer, Director
- Aleksandar VacicExecutive Officer, Promoter
- Michael RubinDirector
- Offering amount
- $25M
- Amount sold
- $23.5M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.